Healthcare Industry News: Titan Spine
News Release - September 8, 2014
Titan Spine Announces Guarantee for Its Spinal Interbody Fusion DevicesSpine Device Warranty Demonstrates Significant Confidence in Products
MEQUON, Wis.--(Healthcare Sales & Marketing Network)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that the Company is offering a warranty for its Endoskeleton® line of spinal interbody fusion devices. Through the warranty, Titan Spine provides a one-time free replacement of any eligible Titan spinal interbody fusion device if revision surgery is required within the five year warranty period, as outlined within the terms of the agreement.
“Titan Spine is dedicated to developing interbody devices that offer physicians and patients the opportunity for successful spinal surgeries, and we continue to stand behind our products,” said Peter Ullrich, MD, former surgeon and Chief Executive Officer of Titan Spine. “Over the last few months, we’ve received positive feedback regarding our warranty from the field and we are proud to offer it as a testament to the knowledge that our products are engineered for optimal success in patients. Ultimately, the warranty demonstrates the significant confidence we have in our products and the science validating our surface technology. On the heels of the recent FDA clearance of our TL lateral system and winning the Whitecloud award for Best Basic Research from the Scoliosis Research Society (SRS) at IMAST 2014, we look forward to accelerating momentum by providing our physician customers an additional reason to trust that our products will successfully perform in patients.”
Titan’s full line of Endoskeleton® devices features the Company’s proprietary implant surface technology, consisting of a unique combination of roughened topographies at the macro, micro, and cellular levels. This combination of surface topographies is designed to create an optimal host-bone response and actively participate in the fusion process by promoting new bone growth, encouraging natural production of bone morphogenetic proteins (BMP’s) and creating the potential for a faster and more robust fusion.
”In my experience, this is the first time that a device company in the spine market has offered such a guarantee,” commented Paul Slosar, M.D., Chief Medical Officer for Titan Spine. “Titan’s line of interbody devices has a unique advantage with its ability to promote specific cellular behavior that supports an advanced environment for bone growth and fusion. This warranty highlights the recognition that our engineered spine implants continue to lead the surface technology space.”
For more information about Titan’s warranty of its Endoskeleton® line of interbody fusion devices, please visit www.titanspine.com or contact your Titan sales representative / distributor.
About Titan Spine
Titan Spine, LLC is a surface technology company focused on the design and manufacture of interbody fusion devices for the spine. The company is committed to advancing the science of surface engineering to enhance the treatment of various pathologies of the spine that require fusion. Titan Spine, located in Mequon, Wisconsin and Laichingen, Germany, markets a full line of Endoskeleton® interbody devices featuring its proprietary textured surface in the U.S. and portions of Europe, with recent market approvals in Australia and New Zealand, through its sales force and a network of independent distributors. The Company’s surface technology has been increasingly recognized by industry and recently, a research paper evaluating its surface technology was awarded the prestigious Whitecloud Award for Best Basic Science Research from the Scoliosis Research Society during the 21st International Meeting on Advanced Spine Techniques (IMAST). To learn more, visit www.titanspine.com.
Source: Titan Spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.